Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Lupus Nephritis × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 511 Neoplasms 380 Lymphoma 341 Prostatic Neoplasms 290 Melanoma 284 Carcinoma, Non-Small-Cell Lung 278 Precursor Cell Lymphoblastic Leukemia-Lymphoma 263 Lung Neoplasms 257 Leukemia, Lymphocytic, Chronic, B-Cell 249 Leukemia, Myeloid, Acute 236 Leukemia 235 Lymphoma, Non-Hodgkin 227 Colonic Neoplasms 226 Ovarian Neoplasms 208 Lymphoma, Large B-Cell, Diffuse 208 Multiple Myeloma 206 Brain Neoplasms 206 Colorectal Neoplasms 202 Lymphoma, Follicular 201 Rectal Neoplasms 194 Burkitt Lymphoma 183 Neoplasm Metastasis 180 Carcinoma, Renal Cell 172 Glioblastoma 169 Sarcoma 168 Lymphoma, Mantle-Cell 166 Pancreatic Neoplasms 157 Lymphoma, B-Cell, Marginal Zone 145 Unspecified Adult Solid Tumor, Protocol Specific 141 Hodgkin Disease 141

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00447265 2013-02-12

Etanercept for the Treatment of Lupus Nephritis

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Terminated

1 enrolled 15 charts

Lupus Nephritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡